Toronto, Ontario — May 5, 2026 — Leads & Copy — Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX0) has announced that Horizon Health has purchased an additional 100 Venowave™ units, following the initial 100-unit shipment delivered in late March 2026.
Horizon Health’s decision to double its commitment highlights the demand for the Venowave™ mobile compression device within its vascular patient population, according to Therma Bright.
According to Therma Bright, the technology has reached patients requiring mobile solutions for circulation and DVT prevention through Horizon’s distribution channels.
Therma Bright CEO Rob Fia stated the second order validates the belief that Venowave™ is a solution for vascular patients. Fia added that the follow-on purchase confirms that Therma Bright’s distribution strategy is working, and the company is focused on supporting Horizon as they scale volumes across their network.
Horizon Health Co-CEO Steve Ebner reported that the feedback from distribution channels for the first 100 Venowave™ units has been exceptional, with clinical teams and patients reporting high satisfaction with the device’s performance and ease of use.
Horizon Health Co-CEO James Stadler stated that the initial success with their vascular patient base drove the second order. Stadler anticipates a potential ramp-up in order frequency and volume as they move through the remainder of the year, based on positive outcomes and the efficiency of current distribution channels.
Therma Bright views these consecutive 100-unit orders as the foundation for a long-term revenue stream, as Horizon Health currently moves over 35,000 compression products annually.
Both companies are working to monitor patient outcomes and supply chain efficiency to support a projected increase in order sizes as Venowave™ becomes a staple in Horizon’s vascular care protocols.
Venowave™ is a battery-operated peristaltic pump worn on the calf, designed to increase blood flow in the veins to prevent blood clots and treat symptoms of chronic venous insufficiency. It is a mobile mechanical compression system reimbursable in the United States through Medicare with permanent HCPCS code, E0683.
Horizon Health focuses on the surgical and vascular markets, partnering with medical institutions and surgical groups to provide patients with integrated care solutions. Horizon Health’s network encompasses hospitals in the United States, supported by a team focused on medical devices.
Therma Bright specializes in advanced diagnostic and medical device technologies with solutions for vascular health, respiratory diagnostics, and topical treatments. Therma Bright is listed on the TSX Venture Exchange (THRM), the OTCQB (TBRIF), and the Frankfurt Stock Exchange (JNX0).
Source: Therma Bright Inc.
